Additionally, as previously mentioned, Syk inhibitors, such as BAY61-3606, R406 or Piceatannol, have been used in the treatment of MM in vitro, showing inhibition of the proliferation and induction of apoptosis mediated by the inhibition of MAPKs such as ERK and p38 [71]. The gene discussed is MAPK14; the disease is Miyoshi myopathy.